| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/16/2009 | WO2009089138A1 Oral administration of ixabepilone |
| 07/16/2009 | WO2009089132A1 Substituted-aryl-2-phenylethyl-1h-imidazole compounds as subtype selective modulators of alpha 2b and/or alpha 2c adrenergic receptors |
| 07/16/2009 | WO2009089121A2 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 07/16/2009 | WO2009089107A1 Dietary compositions for promoting weight loss |
| 07/16/2009 | WO2009089098A1 Methods for the treatment of cancers |
| 07/16/2009 | WO2009089093A1 Thyroid hormone receptor agonists |
| 07/16/2009 | WO2009089083A1 Trpa1 antagonists |
| 07/16/2009 | WO2009089082A1 Trpa1 antagonists |
| 07/16/2009 | WO2009089070A2 Compositions and methods for reducing particle penetration through mucus |
| 07/16/2009 | WO2009089057A1 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 07/16/2009 | WO2009089049A1 Rasagiline formulations, their preparation and use |
| 07/16/2009 | WO2009089042A1 Pyrazole pyrazine amine compounds as kinase inhibitors, compositions thereof and methods of treatment therewith |
| 07/16/2009 | WO2009089027A1 Phosphodiesterase inhibitors |
| 07/16/2009 | WO2009089024A1 Neuroactive steroid compositions and methods of use therefor |
| 07/16/2009 | WO2009089011A2 Resveratrol formulations |
| 07/16/2009 | WO2009088997A1 Lactam inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 07/16/2009 | WO2009088992A2 Ribonuclease and thiazolidinedione compounds and their use in methods to treat cancer |
| 07/16/2009 | WO2009088959A1 Enhanced delivery of antifungal agents |
| 07/16/2009 | WO2009088939A2 Compositions and methods for treating neurodegenerative diseases |
| 07/16/2009 | WO2009088892A1 Liver screening method |
| 07/16/2009 | WO2009088879A1 Combinations to improve animal health and performance |
| 07/16/2009 | WO2009088860A2 A method of preventing contrast-induced nephropathy |
| 07/16/2009 | WO2009088857A1 Crystalline solvated forms of (r) -2- [ [ [3-methyl-4- (2, 2, 2-trifluoroethoxy) -2-pyridinyl] methyl] sulfinyl] -1h-benz imidazole |
| 07/16/2009 | WO2009088854A1 Epoxy-guaiane derivatives and treatment of cancer |
| 07/16/2009 | WO2009088838A2 Triarylmethane analogs and their use in treating cancers |
| 07/16/2009 | WO2009088831A2 Method of inhibiting abcg2 and other treatment methods |
| 07/16/2009 | WO2009088738A2 Compositions and methods for increasing muscle mass, strength, and functional performance in the elderly |
| 07/16/2009 | WO2009088719A1 Inhibitors of cytochrome p450 |
| 07/16/2009 | WO2009088618A1 Method of aralkylation of 4'-hydroxyl group of anthracyclins |
| 07/16/2009 | WO2009088553A1 Dry powder drug delivery formulations, methods of use, and devices therefore |
| 07/16/2009 | WO2009088549A2 Methods of inhibiting bacterial virulence and compounds relating thereto |
| 07/16/2009 | WO2009088531A1 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (s1p) receptor antagonist biological activity |
| 07/16/2009 | WO2009088530A1 Pterin analog for treating bh4 responsive condition |
| 07/16/2009 | WO2009088518A1 A2b adenosine receptor antagonists for the treatment of cancer |
| 07/16/2009 | WO2009088433A1 Compositions comprising unsaturated fatty acids and nitric oxide releasing compounds and use thereof for enhancing congnitive and related functions |
| 07/16/2009 | WO2009088414A2 Oral pharmaceutical dosage forms |
| 07/16/2009 | WO2009088402A2 Identification of bacterial autoinducer and use in treating bacterial pathogenicity |
| 07/16/2009 | WO2009088125A1 A composition for sanitary supplies comprising mucosal immunoadjuvant and a preparation method thereof |
| 07/16/2009 | WO2009088119A1 Composition for preventing or treating dry eye syndrome comprising poly-gamma-glutamic acid |
| 07/16/2009 | WO2009088118A1 Pharmaceutical composition for treating corneal wound comprising poly-gamma-glutamic acid |
| 07/16/2009 | WO2009088063A1 Pharmaceutical composition, use of 2-iminopyrrolidine derivative for production of pharmaceutical composition, and kit for treatment or amelioration of heart diseases |
| 07/16/2009 | WO2009088042A1 Atomizing agent for prevention of infection with influenza virus |
| 07/16/2009 | WO2009088006A1 Combined pharmaceutical agent |
| 07/16/2009 | WO2009087988A1 Composition for reducing oxidative stress and/or side effects occurring during cancer chemotherapy or improving nutritional status during cancer chemotherapy |
| 07/16/2009 | WO2009087987A1 Composition for improving nutritional status, reducing frequency of fever and/or increasing immunocompetence of elderly |
| 07/16/2009 | WO2009087949A1 Compound having heterocyclic ring, and use thereof |
| 07/16/2009 | WO2009087938A1 Capsule formulation |
| 07/16/2009 | WO2009087900A1 Pharmaceutical agent for prevention or treatment of diseases accompanied by intraocular vascular hyperpermeability |
| 07/16/2009 | WO2009087682A2 Stabilized injectable formulation of pregabalin |
| 07/16/2009 | WO2009087678A2 Nanodispersion |
| 07/16/2009 | WO2009087675A2 Coated extended release pharmaceutical compositions of levetiracetam |
| 07/16/2009 | WO2009087673A1 Improved process for the manufacture of anagrelide hidrochloride monhydrate |
| 07/16/2009 | WO2009087667A2 Crystalline polymorphic forms of zopiclone, processes for their preparation and their pharmaceutical compositions |
| 07/16/2009 | WO2009087664A1 Process for preparing chemically and chirally pure solifenacin base and its salts |
| 07/16/2009 | WO2009087663A2 Oral controlled release coated tablet |
| 07/16/2009 | WO2009087660A1 Stable oxaliplatin composition for parenteral administration |
| 07/16/2009 | WO2009087658A2 Ketorolac tromethamine containing parenteral formulation |
| 07/16/2009 | WO2009087657A2 Stable pharmaceutical composition of duloxetine and process for its preparation |
| 07/16/2009 | WO2009087649A1 Renin inhibitors |
| 07/16/2009 | WO2009087615A1 Pharmaceutical compositions and methods utilizing a d-amino acid and an antioxidant for treating neuropsychiatric disorders |
| 07/16/2009 | WO2009087602A1 Compositions for use in the treatment and prevention of ulcerative collitis |
| 07/16/2009 | WO2009087568A2 Compositions comprising antioxidant and mitoprotective flavonoids with neuroprotective properties |
| 07/16/2009 | WO2009087564A1 Proline analogs as ligands for cannabinoid receptors for the treatment of pain |
| 07/16/2009 | WO2009087553A1 Kits for administering bisphosphonates |
| 07/16/2009 | WO2009087474A2 Agonists for antimicrobial peptide systems |
| 07/16/2009 | WO2009087410A2 Solid pharmaceutical dosage form |
| 07/16/2009 | WO2009087395A1 Weight reducing compounds |
| 07/16/2009 | WO2009087381A1 Pharmaceutically acceptable salts of 2-{4-[(3s)-piperidin-3- yl]phenyl} -2h-indazole-7-carboxamide |
| 07/16/2009 | WO2009087379A2 Tetrahydrofuro (3, 2 -b) pyrrol- 3 -one derivatives as inhibitors of cysteine proteinases |
| 07/16/2009 | WO2009087354A2 Skincare treatment |
| 07/16/2009 | WO2009087351A1 Use of cannabinoids in combination with an anti-psychotic medicament |
| 07/16/2009 | WO2009087305A1 6-aryl/heteroalkyloxy benzothiazole and benzimidazole derivatives, method for preparing same, application thereof as drugs, pharmaceutical compositions and novel use in particular as c-met inhibitors |
| 07/16/2009 | WO2009087286A2 Use of a 1-n-(halo-3-pyridylmethyl)-n-methylamino-1-alkylamino-2-nitroethylene derivative for preparing a topical veterinary pharmaceutical composition for combating external parasites |
| 07/16/2009 | WO2009087285A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/16/2009 | WO2009087238A2 Chemical molecules that inhibit the slicing mechanism for treating diseases resulting from splicing anomalies |
| 07/16/2009 | WO2009087224A1 Pyrimidines as kinase inhibitors |
| 07/16/2009 | WO2009087220A1 Use of thiazoloimidazoles, thiazolotetrazoles and thiazolotriazoles as mglur5 antagonists |
| 07/16/2009 | WO2009087218A1 Thiazoltriazoles and thiazolimidazoles as antagonists of the mglur5 receptor |
| 07/16/2009 | WO2009087194A1 Mixture of citric flavonoids to improve ruminal fermentation |
| 07/16/2009 | WO2009087153A1 Tricyclic nitrogen compounds and their use as antibacterial agents |
| 07/16/2009 | WO2009087151A1 Polymorphic forms of moxifloxacin hydrochloride and processes for preparation thereof |
| 07/16/2009 | WO2009087148A2 Analgesic apatitic calcium-phosphate cement |
| 07/16/2009 | WO2009087130A1 Use of a gamma-secretase inhibitor for treating cancer |
| 07/16/2009 | WO2009087127A1 Modulators for amyloid beta |
| 07/16/2009 | WO2009087116A1 Use of spp100 for the treatment of acute mi |
| 07/16/2009 | WO2009087058A1 Process for the preparation of asenapine and intermediate products used in said process |
| 07/16/2009 | WO2009086952A2 Compositions for the treatment of degenerative articular diseases |
| 07/16/2009 | WO2009086835A1 Novel cyanoguanidines |
| 07/16/2009 | WO2009086731A1 New benzimidazole compounds |
| 07/16/2009 | WO2009086720A1 2,3,4,6-tetra-o-acetyl-d-glucopyranosyl-[n,n'-di-(2-chloroethyl)]-phosphoric acid diamide, preparation methods and uses thereof |
| 07/16/2009 | WO2009086705A1 Preparation method of rivastigmine, its intermediates and preparation method of the intermediates |
| 07/16/2009 | WO2009086695A1 Use of extractive of bcg polysaccharide and nucleic acid for preparing medicine for treating allergic dermatosis, and its injection and preparation method |
| 07/16/2009 | WO2009086694A1 Use of extractive of bcg polysaccharide and nucleic acid for preparing medicine for treating viral skin diseases, and its injection and preparation method |
| 07/16/2009 | WO2009086685A1 An alginic acid with low molecular weight, its salts, uses, preparative methods, pharmaceutical compositions and foods |
| 07/16/2009 | WO2009086592A1 Method of increasing metabolism |
| 07/16/2009 | WO2009067791A4 Compositions and methods for producing vascular occlusion using a solid-phase platelet binding agent |
| 07/16/2009 | WO2009067686A8 Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof |
| 07/16/2009 | WO2009067166A3 Non-nucleoside reverse transcriptase inhibitors |
| 07/16/2009 | WO2009066956A3 Lyophilized pharmaceutical composition with improved reconstitution time containing taxane derivatives and method of manufacturing the same |
| 07/16/2009 | WO2009065946A3 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition |